Trueblue (TBI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue declined 17% year-over-year to $396 million amid economic uncertainty and reduced client hiring, with softness across most verticals except renewable energy and commercial driving services.
Net loss was $105 million, including a $45 million non-cash impairment and a $55 million deferred tax asset valuation allowance.
Adjusted EBITDA was $1 million, reflecting significant cost management and operational streamlining.
SG&A expense was reduced by 20% to $97 million, reflecting cost actions and organizational simplification.
Strong liquidity maintained with zero debt, $26 million in cash, and $132 million in borrowing availability.
Financial highlights
Revenue: $396 million for Q2 2024, down 17% year-over-year.
Net loss: $105 million, including significant non-cash impairment and tax charges.
Adjusted net loss was $11 million; adjusted EBITDA was $1 million.
Gross margin was 26.4%, down 100 basis points year-over-year due to unfavorable revenue mix and pricing pressures.
SG&A reduced by 20% year-over-year, with $70 million in cost reductions, much of which is expected to be permanent.
Outlook and guidance
Q3 2024 revenue expected to decline 14%-20% year-over-year, with a 1-point drag from the Canada business sale.
SG&A for Q3 projected at $99-$103 million, about $20 million lower than prior year, including $2 million in workforce reduction costs.
Gross margin for Q3 2024 anticipated to decline 20–60 basis points year-over-year due to business mix.
FY 2024 CapEx and depreciation each expected at $23–$27 million.
Effective tax rate for FY 2024 expected at -35% to -40% due to valuation allowance.
Latest events from Trueblue
- Board refreshment and profitability initiatives advance as proxy contest with EHS continues.TBI
Proxy Filing3 Mar 2026 - Revenue up 8% to $418M, but net loss widened on impairment; margin pressure persists.TBI
Q4 202518 Feb 2026 - Digital innovation and market expansion drive growth and margin gains in a fragmented staffing sector.TBI
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 revenue dropped 19.2% with a $59.1M goodwill impairment and strong cost controls.TBI
Q3 202416 Jan 2026 - Board refreshment and strategic initiatives position the company for long-term growth.TBI
Proxy Filing9 Jan 2026 - Board refreshment and strategic focus highlighted as proxy process begins for 2026.TBI
Proxy Filing9 Jan 2026 - Q4 revenue fell 22% but margin gains, cost cuts, and healthcare expansion support recovery.TBI
Q4 202424 Dec 2025 - Board appointments and refreshment aim to drive growth, oversight, and long-term value.TBI
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, incentive plan, and auditor, with strong governance and ESG focus.TBI
Proxy Filing1 Dec 2025